Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs

Expert Opinion on Drug Delivery

Volumn 9, Issue 6, 2012, Pages 687-700

  Tian, Ye ^a   Mao, Shirui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anticancer drug; Nanocarriers; Oral delivery; Polymeric micelles; Poorly soluble

Indexed keywords

'TAXOL'; ANTINEOPLASTIC AGENT; BUTYRIC ACID; CAMPTOTHECIN; CHITOSAN; CYCLOSPORIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; HYALURONIC ACID; ITRACONAZOLE; KETOCONAZOLE; MACROGOL; MITOMYCIN C; NANOCARRIER; PACLITAXEL; POLOXAMER; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; HYDROPHILICITY; HYDROPHOBICITY; MAXIMUM PLASMA CONCENTRATION; MICELLE; NANOENCAPSULATION; REVIEW; SUSTAINED DRUG RELEASE;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICELLES; PARTICLE SIZE; POLOXAMER; POLYETHYLENE GLYCOLS; SOLUBILITY;

EID: 84862069884     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.681299     Document Type: Review

References (103)

1. Hallaj-Nezhadi S, Lotfipour F, Dass CR. Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy. Pharmazie 2010;65(12):855-9
2. Bromberg L. Polymeric micelles in oral chemotherapy. J Control Release 2008;128(2):99-112
3. Jin Y, Song Y, Zhu X, et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 2012;33(5):1573-82
4. Yao HJ, Ju RJ, Wang XX, et al. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Biomaterials 2011;32(12):3285-302
5. Sun W, Zou W, Huang G, et al. Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration. J Drug Target 2008;16(5):357-65 (Pubitemid 351935733)
6. Ghosh S, Chiang PC, Wahlstrom JL, et al. Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. Basic Clin Pharmacol Toxicol 2008;102(5):453-8 (Pubitemid 351537788)
7. Zhang J, Zheng Z, Gao Y, et al. Spray-dried oil-in-water emulsion to improve the intestinal absorption and oral bioavailability of ZLR-8, a nitric oxide-releasing derivative of diclofenac. J Pharm Pharmacol 2011;63(12):1531-8
8. Jiang T, Han N, Zhao B, et al. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm 2012 (in press)
9. Yang K, Chen SW, Chen R, et al. Experimental study of cisplatin loaded polylactic acid-polyethylene glycol nano-particles for targeting oral carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi 2005;23(5):445-8
10. Matsumura Y, Hamaguchi T, Ura T, et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, amicelle-encapsulated doxorubicin. Br J Cancer 2004;91(10):1775-81 (Pubitemid 39664964)
11. Lim WT, Tan EH, Toh CK, et al. Phase I pharmacokinetic study of aweekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. Ann Oncol 2010;21(2):382-8
12. Mo R, Jin X, Li N, et al. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-Osulfate chitosan micelles. Biomaterials 2011;32(20):4609-20
13. Zhang Z, Feng SS. Self-assembled nanoparticles of poly(lactide) - vitamin ETPGS copolymers for oral chemotherapy. Int J Pharm 2006;324(2):191-8 (Pubitemid 44550164)
14. Shen LJ, Shen WC. Drug evaluation: ADI-PEG-20 - a PEGylated arginine deiminase for arginine-auxotrophic cancers. Curr Opin Mol Ther 2006;8(3):240-8
15. Maruyama K. PEG-liposome in DDS and clinical studies. Nippon Rinsho 1998;56(3):632-7
16. Sezgin Z, Yuksel N, Baykara T. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration. Int J Pharm 2007;332(1-2):161-7 (Pubitemid 46227770)
17. Sweet DM, Kolhatkar RB, Ray A, et al. Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery. J Control Release 2009;138(1):78-85
18. Ould-Ouali L, Arien A, Rosenblatt J, et al. Biodegradable self-assembling PEG-copolymer as vehicle for poorly water-soluble drugs. Pharm Res 2004;21(9):1581-90 (Pubitemid 41184388)
19. Ould-Ouali L, Noppe M, Langlois X, et al. Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone. J Control Release 2005;102(3):657-68 (Pubitemid 40170208)
20. Vandermeulen G, Rouxhet L, Arien A, et al. Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsiloncaprolactone-co- trimethylenecarbonate) polymeric micelles. Int J Pharm 2006;309(1-2):234-40 (Pubitemid 43129487)
21. Danhier F, Magotteaux N, Ucakar B, et al. Novel self-assembling PEG-p-(CLco-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. Eur J Pharm Biopharm 2009;73(2):230-8
22. Zacchigna M, Cateni F, Di Luca G, et al. A simple method for the preparation of PEG-6-mercaptopurine for oral administration. Bioorg Med Chem Lett 2007;17(23):6607-9 (Pubitemid 350026319)
23. Lee SC, Huh KM, Lee J, et al. Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization. Biomacromolecules 2007;8(1):202-8 (Pubitemid 46140493)
24. Zhang Y, Li X, Zhou Y, et al. Preparation and evaluation of poly (Ethylene Glycol)-poly(Lactide) micelles as nanocarriers for oral delivery of cyclosporine A. Nanoscale Res Lett 2010;5(6):917-25
25. Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 2010;62(1):12-27
26. Trickler WJ, Nagvekar AA, Dash AK. A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS PharmSciTech 2008;9(2):486-93
27. Park JH, Saravanakumar G, Kim K, et al. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev 2010;62(1):28-41
28. Mo R, Xiao Y, Sun M, et al. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption. Int J Pharm 2011;409(1-2):38-45
29. Liao YH, Jones SA, Forbes B, et al. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv 2005;12(6):327-42 (Pubitemid 41572107)
30. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 2004;83(7):317-25 (Pubitemid 39307169)
31. Aruffo A, Stamenkovic I, Melnick M, et al. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61(7):1303-13
32. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur JCell Biol 2006;85(8):699-715 (Pubitemid 44070579)
33. Culty M, Miyake K, Kincade PW, et al. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 1990;111(6 Pt 1):2765-74 (Pubitemid 120014557)
34. Dekel Y, Glucksam Y, Margalit R. Novel fibrillar insulin formulations for oral administration: formulation and in vivo studies in diabetic mice. J Control Release 2010;143(1):128-35
35. Choi KY, Chung H, Min KH, et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010;31(1):106-14
36. Kim J, Kim KS, Jiang G, et al. In vivo real-time bioimaging of hyaluronic acid derivatives using quantum dots. Biopolymers 2008;89(12):1144-53
37. Lee H, Lee K, Park TG. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem 2008;19(6):1319-25 (Pubitemid 351874956)
38. Xin D, Wang Y, Xiang J. The use of amino Acid linkers in the conjugation of paclitaxel with hyaluronic acid as drug delivery system: synthesis, self-assembled property, drug release, and in vitro efficiency. Pharm Res 2010;27(2):380-9
39. Huang SL, Ling PX, Zhang TM. Oral absorption of hyaluronic acid and phospholipids complexes in rats. World J Gastroenterol 2007;13(6):945-9
40. Oh EJ, Park K, Kim KS, et al. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release 2010;141(1):2-12
41. Armstrong JK, Meiselman HJ, Wenby RB, et al. Modulation of red blood cell aggregation and blood viscosity by the covalent attachment of Pluronic copolymers. Biorheology 2001;38(2-3):239-47 (Pubitemid 32573707)
42. Tsui HW, Hsu YH, Wang JH, et al. Novel behavior of heat of micellization of pluronics F68 and F88 in aqueous solutions. Langmuir 2008;24(24):13858-62
43. Sharma AK, Zhang L, Li S, et al. Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant. J Control Release 2008;131(3):220-7
44. Batrakova EV, Han HY, Miller DW, et al. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm Res 1998;15(10):1525-32 (Pubitemid 28465737)
45. Kwon SH, Kim SY, Ha KW, et al. Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery. Arch Pharm Res 2007;30(9):1138-43
46. Mu CF, Balakrishnan P, Cui FD, et al. The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials 2010;31(8):2371-9
47. Yang Y, Wang J, Zhang X, et al. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel. J Control Release 2009;135(2):175-82
48. Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16(10):1550-6 (Pubitemid 29510551)
49. Varma MV, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin ETPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 2005;25(4-5):445-53 (Pubitemid 40853872)
50. Mu L, Feng SS. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm Res 2003;20(11):1864-72 (Pubitemid 37449463)
51. Lee SH, Zhang Z, Feng SS. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. Biomaterials 2007;28(11):2041-50 (Pubitemid 46188359)
52. Collnot EM, Baldes C, Wempe MF, et al. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm 2007;4(3):465-74 (Pubitemid 46983960)
53. Dabholkar RD, Sawant RM, Mongayt DA, et al. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 2006;315(1-2):148-57 (Pubitemid 43674120)
54. Ke WT, Lin SY, Ho HO, et al. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as asurfactant for the oral delivery of protein drugs. J Control Release 2005;102(2):489-507
55. Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005;26(15):2713-22
56. Gao Y, Li LB, Zhai G. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids Surf B Biointerfaces 2008;64(2):194-9
57. Lim EK, Yang J, Park MY, et al. Synthesis of water soluble PEGylated magnetic complexes using mPEG-fatty acid for biomedical applications. Colloids Surf B Biointerfaces 2008;64(1):111-17
58. Joes AG. Crystallization process systems. An imprint of Elsevier Science 2002;ISBN 0 7506 5520 8
59. Jones M, Leroux J. Polymeric micelles -a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999;48(2):101-11 (Pubitemid 29401986)
60. Baines LF, Armes SP, Billingham NC, et al. Micellization of Poly (2-(dimethylamino)Ethyl Methacrylate-Block-Methyl methacrylate) Copolymers in Aqueous Solution. ETATS-UNIS: American Chemical Society; Washington, DC: 1996
61. Dreher MR, Simnick AJ, Fischer K, et al. Temperature triggered self-assembly of polypeptides into multivalent spherical micelles. J Am Chem Soc 2008;130(2):687-94 (Pubitemid 351455582)
62. Riess GR. Micellization of block copolymers. Prog Polym Sci 2003;28:1107-70
63. Hu FQ, Ren GF, Yuan H, et al. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf B Biointerfaces 2006;50(2):97-103 (Pubitemid 43946659)
64. Malmsten M. Surfactants and polymers in drug delivery. Informa Healthcare; 2002;ISBN-13: 978-0824708047
65. Park JH, Kwon S, Nam JO, et al. Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery. J Control Release 2004;95(3):579-88 (Pubitemid 38340507)
66. Blanco E, Bey EA, Dong Y, et al. Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells. J Control Release 2007;122(3):365-74 (Pubitemid 47404665)
67. Letchford K, Liggins R, Burt H. Solubilization of hydrophobic drugs by methoxy poly(Ethylene Clycol)-blockpolycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations. Paharmacetics Preformulation Drug Deliv 2007;97(3):1179-91
68. Liu J, Xiao Y, Allen C. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent. J Pharm Sci 2004;93:132-43 (Pubitemid 38081821)
69. Zhang JX, Li XJ, Qiu LY, et al. Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: preparation, in vitro and in vivo evaluation. J Control Release 2006;116(3):322-9 (Pubitemid 44827410)
70. Prompruk K, Govender T, Zhang S, et al. Synthesis of a novel PEG-blockpoly( aspartic acid-stat-phenylalanine) copolymer shows potential for formation of a micellar drug carrier. Int J Pharm 2005;297(1-2):242-53 (Pubitemid 40720283)
71. Kim JH, Kim YS, Park K, et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 2008;127(1):41-9
72. Zhang C, Qu G, Sun Y, et al. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 2008;29(9):1233-41
73. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001;73(2-3):137-72 (Pubitemid 32544594)
74. Kim S, Shi Y, Kim JY, et al. Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin Drug Deliv 2010;7(1):49-62
75. Yuan H, Lu LJ, Du YZ, et al. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption. Mol Pharm 2011;8(1):225-38
76. Rekha MR, Sharma CP. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J Control Release 2009;135(2):144-51
77. Park KM, Bae JW, Joung YK, et al. Nanoaggregate of thermosensitive chitosan-pluronic for sustained release of hydrophobic drug. Colloids Surf B Biointerfaces 2008;63(1):1-6
78. Yang TF, Chen CN, Chen MC, et al. Shell-crosslinked Pluronic L121 micelles as a drug delivery vehicle. Biomaterials 2007;28(4):725-34
79. Daugherty AL, Mrsny RJ. Transcellular uptake mechanisms of the intestinal epithelial barrier part one. Pharm Sci Technol Today 1999;4(2):144-51 (Pubitemid 29195747)
80. Norris DA, Puri N, Sinko PJ. The effect of physical barriers and properties on the oral absorption of particulates. Adv Drug Deliv Rev 1998;34(2-3):135-54 (Pubitemid 28535109)
81. Allen C, Yu Y, Eisenberg A, et al. Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles. Biochim Biophys Acta 1999;1421(1):32-8 (Pubitemid 29421855)
82. Mathot F, des Rieux A, Arien A, et al. Transport mechanisms of mmePEG750P (CL-co-TMC) polymeric micelles across the intestinal barrier. J Control Release 2007;124(3):134-43 (Pubitemid 350110487)
83. Mathot F, van Beijsterveldt L, Preat V, et al. Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. J Control Release 2006;111(1-2):47-55 (Pubitemid 43289994)
84. Sadeghi AM, Dorkoosh FA, Avadi MR, et al. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur JPharm Biopharm 2008;70(1):270-8
85. Takeuchi H, Thongborisute J, Matsui Y, et al. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev 2005;57(11):1583-94 (Pubitemid 41443471)
86. Lapcik L Jr, Lapcik L, De Smedt S, et al. Hyaluronan: preparation, structure, properties, and applications. Chem Rev 1998;98(8):2663-84
87. Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev 2001;52(2):117-26 (Pubitemid 33079167)
88. Woo JS, Lee CH, Shim CK, et al. Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031. Pharm Res 2003;20(1):24-30 (Pubitemid 36152913)
89. Mu L, Seow PH. Application of TPGS in polymeric nanoparticulate drug delivery system. Colloids Surf B Biointerfaces 2006;47(1):90-7 (Pubitemid 43111610)
90. Andreas BS. Oral delivery of macromolecular drugs. Springer Dordrecht Heidelberg London New York 2009;ISBN: 978-1-4419-0199-6
91. des Rieux A, Ragnarsson EG, Gullberg E, et al. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci 2005;25(4-5):455-65 (Pubitemid 40853873)
92. Koch AM, Reynolds F, Kircher MF, et al. Uptake and metabolism of a dual fluorochrome tat-nanoparticle in HeLa cells. Bioconjug Chem 2003;14(6):1115-21 (Pubitemid 37449038)
93. Son YJ, Jang JS, Cho YW, et al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release 2003;91(1-2):135-45 (Pubitemid 37288884)
94. Zhang J, Chen XG, Peng WB, et al. Uptake of oleoyl-chitosan nanoparticles by A549 cells. Nanomedicine 2008;4(3):208-14
95. Alakhov V, Pietrzynski G, Patel K, et al. Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate. J Pharm Pharmacol 2004;56(10):1233-41 (Pubitemid 39368993)
96. Lee E, Kim H, Lee IH, et al. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. J Control Release 2009;140(2):79-85
97. Duhem N, Rolland J, Riva R, et al. Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs. Int J Pharm 2011
98. Li H, Huo M, Zhou J, et al. Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system. J Pharm Sci 2010;99(11):4543-53
99. Wei Z, Hao J, Yuan S, et al. Paclitaxel-loaded Pluronic P123/ F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm 2009;376(1-2):176-85
100. Wang J, Wang R, Li LB. Preparation and properties of hydroxycamptothecin- loaded nanoparticles made of amphiphilic copolymer and normal polymer. J Colloid Interface Sci 2009;336(2):808-13
101. Mu L, Elbayoumi TA, Torchilin VP. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 2005;306(1-2):142-9 (Pubitemid 41643148)
102. Li PY, Lai PS, Hung WC, et al. Poly (L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells. Biomacromolecules 2010;11(10):2576-82
103. Zhang Z, Feng SS. Nanoparticles of poly (lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 2006;27(2):262-70 (Pubitemid 41278528)